Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded by Wall Street Zen to Strong-Buy Rating

Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded by Wall Street Zen to Strong-Buy Rating

Wall Street Zen upgraded Regeneron Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a research report on Sunday.

Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a buy rating to a strong-buy rating in a report published on Sunday,Wall Street Zen reports. Several other research firms have also recently weighed in on REGN. Guggenheim raised their price target on Regeneron Pharmaceuticals from $1,000.00 to $1,030.00 and gave the […]